News

Athersys achieves important milestones in commercial collaborations with Bristol-Myers Squibb and Angiotech.

After building up a strong base of customers in the USA and Europe over the past three years, TTP LabTech have now appointed distributors for Japan, India and Australia/New Zealand.

The technology enhances the level of expression of secreted polypeptides in microorganisms for use in the development of protein therapeutics.

Partnership brings predicted LogP and related property values to more than 5 million chemical structures online.

This announcement builds upon PerkinElmer's recent acquisition of Evotec Technologies, a provider of high-performance cellular screening systems.

BioPark Hertfordshire, the new ‘Outer London’ science park offers established pharma and growing life science companies access to world-class chemistry and biology laboratory facilities.

The goal of the collaboration is to provide early tools for in vitro safety evaluation of lead compounds.

The new business unit will focus on developing a microscopy and optical spectroscopy business that can be leveraged into the electronics, materials testing, life sciences and chemical analysis markets.

NiKem will make its integrated platform available to Neurotune, including medicinal, parallel and analytical chemistry, exploratory ADMET profiling and in vivo PK.

A multi-million pound visionary medical project that will recruit 500,000 people across Britain to help find out much more about curing many life threatening and debilitating diseases gets underway in Manchester.